Abiopharma

CERTARA, INC. (CERT)

Symbol	CERT
Name	CERTARA, INC.
Sector	TECHNOLOGY
Region	North America
Industry	Computer Software: Prepackaged Software
Address	100 OVERLOOK CENTER,SUITE 101, PRINCETON, New Jersey, 08540, United States
Telephone	+1 609 716-7900
Fax	—
Email	—
Website	https://www.certara.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	—
Description	Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States. Additional info from NASDAQ: Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States.

2026-04-28 17:16

New Form D - Certara, Inc. Filed: 2026-04-28 AccNo: 0001104659-26-050361 Size: 18 KB

2026-04-22 11:00

(50% Neutral) CERTARA, INC. (CERT) Announces Business Combination

2026-04-22 11:00

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

2026-04-20 10:00

Cerrado Gold Announces Q1 2026 Production Results at Its Minera Don Nicolas Mine in Argentina

2026-04-09 20:15

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

2026-04-06 18:48

New Form SCHEDULE 13G/A - Certara, Inc. Filed: 2026-04-06 AccNo: 0000814133-26-000032 Size: 7 KB

2026-04-06 18:41

New Form SCHEDULE 13G/A - Certara, Inc. Filed: 2026-04-06 AccNo: 0000814133-26-000031 Size: 7 KB

2026-04-03 20:11

Pedersen Leif E 🟡 adjusted position in 2.9K shares (3 derivative) of Certara, Inc. (CERT) at $5.70 Transaction Date: Apr 01, 2026 | Filing ID: 000003

2026-04-03 20:10

McKemey Adrian 🟡 adjusted position in 2.6K shares (1 derivative) of Certara, Inc. (CERT) at $5.70 Transaction Date: Apr 01, 2026 | Filing ID: 000003

2026-04-03 20:09

Corcoran Daniel 🟡 adjusted position in 5.8K shares (1 derivative) of Certara, Inc. (CERT) at $5.70 Transaction Date: Apr 01, 2026 | Filing ID: 000003